Literature DB >> 18947484

[Clinical features of recurrent Kawasaki disease in 20 children].

Li-Xia Zou1, Fang-Qi Gong.   

Abstract

OBJECTIVE: To investigate the clinical features of recurrent Kawasaki disease (KD) and the relationship of recurrent KD with coronary artery lesions.
METHODS: The medical data of 20 children with recurrent KD who were admitted to the Children's Hospital from January 1998 to May 2007 were retrospectively studied. Their clinical features were compared with those of children with initial KD.
RESULTS: The incidence of recurrent KD was 1.34% (20/1489). KD relapsed 2 months to 4.6 years (average: 1.2 years) after the first episode in the 20 children. Compared with the initial KD group, the clinical symptoms in the recurrent KD group were incomplete, complicated and less severe. The period of fever, platelet count, C-reactive protein and ESR were remarkably reduced in the recurrent KD group, but the incidence of coronary artery lesions increased significantly compared with the initial KD group (40% vs 25%; P<0.05).
CONCLUSIONS: The clinical symptoms of recurrent KD were incomplete in children. Recurrent KD was associated with an increased incidence of coronary artery lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18947484

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  3 in total

1.  Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years.

Authors:  Hua Zhu; Shao-Fei Yu; Yu-Xin Bai; Yan-Yan Liang; Xue-Wen Su; Jing-Ying Pan
Journal:  Exp Ther Med       Date:  2015-05-11       Impact factor: 2.447

2.  [Clinical features of children with recurrent Kawasaki disease: a Meta analysis].

Authors:  Gang Luo; Si-Lin Pan; Si-Bao Wang; Zhan-Hui DU; Zhi-Xian Ji
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-12

3.  Recurrent Kawasaki disease: USA and Japan.

Authors:  Ryan A Maddox; Robert C Holman; Ritei Uehara; Laura S Callinan; Jodie L Guest; Lawrence B Schonberger; Yosikazu Nakamura; Mayumi Yashiro; Ermias D Belay
Journal:  Pediatr Int       Date:  2015-11-05       Impact factor: 1.524

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.